NCT07389473Recruiting
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 20 Aug 2025
- Start date
- 17 Apr 2024
- Primary completion date
- Dec 2027
- Lead sponsor
- Gaize
- Diseases
- Bipolar disorder
- NCT number
- NCT07389473
What you commit to
- Study type: Observational
- Planned participants: 50
- From 17 Apr 2024 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Enrolled in, or participated in another clinical trial within 30 days before the study
- Having a prosthetic eye, missing eye, or wearer of an eye patch LASIK or other eye surgery within the prior 21 days.
- Had your eyes dilated by a medical doctor in the previous 24 hours.
Other illness
- Photosensitive epilepsy
- Medical Conditions: Participants with medical conditions or medications that could significantly affect cognitive and motor functions are excluded. Participants with conditions such as Glaucoma, macular degeneration, cataracts, lazy eye (amblyopia), or optic neuritis, or genetic anisocoria (unequal pupil size) will be excluded.
- Pregnancy: Pregnant individuals will be excluded from the study due to the potential risks associated with psychiatric medications.
- History of Severe Motion Sickness: Participants with a history of severe motion sickness in VR environments may be excluded, as they may not tolerate the VR headset well.
Other
- Diagnosed with clinical blindness
- Current or past head inject/ traumatic brain injury (TBI)
- Potential participants who are unable to provide consent for the study.
Who the study is looking for
- Adults aged between 18 and 65, having given written informed consent to participate in the research trial.
- Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months.
- Normal or corrected to normal vision using either glasses or contact lenses, or surgery.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gaize Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.